Recombinant nerve growth factor
US5683894A · kind A · utility
19Cited by
0References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 7, 1991 |
| Grant date | Nov 4, 1997 |
| Priority date | — |
| Expiry date | Mar 7, 2011 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K14/48
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
A method for producing pure, active, mature recombinant Nerve Growth Factor-beta is disclosed, as is the protein so produced.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.